Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2012
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781432A Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
11/14/2012CN102775424A Preparation method for levofloxacin impurity
11/14/2012CN102093388B Method for preparing decarboxylated levofloxacin
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/13/2012US8309728 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
11/13/2012US8309578 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
11/13/2012US8308795 Drug-delivery endovascular stent and method of forming the same
11/13/2012CA2680262C Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
11/13/2012CA2518234C Thiolactones
11/08/2012WO2012151361A1 Carbamoylpyridone derivatives
11/08/2012WO2012150561A1 Rifaximin dimethylformamide solvate
11/08/2012WO2012149633A1 Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents
11/08/2012US20120283285 Treatment of solid tumors with rapamycin derivatives
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283241 Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/08/2012US20120283220 Antofine and cryptopleurine derivatives as anticancer agents
11/08/2012CA2834829A1 Rifaximin dimethylformamide solvate
11/08/2012CA2833283A1 Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2520568A1 Spirocyclic nitriles as inhibitors of protease
11/07/2012CN102770433A Novel microbicides
11/07/2012CN102770425A Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
11/07/2012CN102770024A Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
11/07/2012CN102766147A Method for preparing fenspiride and halogen acid salt thereof
11/07/2012CN102766142A Lactam compounds useful as protein kinase inhibitors
11/07/2012CN102070651B Method for preparing organic electrolyte oxaspiro quatemary ammonium salt of super capacitor
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/07/2012CN101541796B Novel substituted diaza spiro pyridinone derivatives for use in MCH-1 mediated diseases
11/07/2012CN101228141B Tetrahydrobenzoxazines as stabilisers
11/07/2012CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012CA2710409C 6h-dibenz0 [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
11/06/2012CA2551178C Polycyclic agents for the treatment of respiratory syncytial virus infections
11/01/2012WO2012148548A1 N-substituted oxazinopteridines and oxazinopteridinones
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277237 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/01/2012US20120277233 Pyridyl-Triazine Inhibitors of Hedgehog Signaling
11/01/2012US20120277223 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/01/2012US20120276124 Maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
11/01/2012US20120276051 Inhibitors of hepatitis c virus
11/01/2012US20120276047 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
11/01/2012CA2827770A1 N-substituted oxazinopteridines and oxazinopteridinones
10/2012
10/31/2012EP2516437A1 Disubstituted heteroaryl-fused pyridines
10/31/2012EP2516435A1 Inhibitors of akt activity
10/31/2012EP2516419A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
10/31/2012EP2155757B1 New progesterone receptor modulators
10/31/2012CN102762577A 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
10/31/2012CN102762576A Benzoxazepin pi3k inhibitor compounds and methods of use
10/31/2012CN102762561A Gamma secretase modulaters
10/31/2012CN102762560A Disubstituted heteroaryl-fused pyridines
10/31/2012CN102762546A Materials for organic light emitting devices
10/31/2012CN102762541A Diazepam derivatives as modulators of chemokine receptors
10/31/2012CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug
10/31/2012CN101941979B New production process of rifamycin sodium
10/31/2012CN101687884B Macrolactone derivatives
10/30/2012US8299242 Synthesis of 2,4-pyrimidinediamines
10/30/2012US8299094 Hepatitis C virus inhibitors
10/26/2012WO2012145255A2 Diazonamide analogs
10/26/2012WO2012143725A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012WO2012143080A2 Materials for organic electroluminescent devices
10/26/2012CA2833956A1 Diazonamide analogs
10/25/2012US20120271046 Nitrogen-containing heterocyclic compounds and methods of making the same
10/25/2012US20120270864 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270842 Inhibitors of Diacylglycerol O-Acyltransferase 1 (DGAT-1) and Uses Thereof
10/25/2012US20120270841 Diazonamide Analogs
10/25/2012US20120270213 Screening method for cell aging
10/25/2012US20120270071 Chromene compound
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/24/2012EP2513113A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
10/24/2012CN102753558A Nitroimidazooxazines and their uses in anti-tubercular therapy
10/24/2012CN102753555A Macrocycles as factor XIA inhibitors
10/24/2012CN102746321A One pot synthesis of tetrazole derivatives of sirolimus
10/24/2012CN102746320A Levofloxacin hydrochloride crystal forms and preparation methods thereof
10/24/2012CN102746296A Oxazolidinone antibiotics
10/24/2012CN101855228B Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
10/23/2012US8293734 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
10/18/2012WO2012141704A1 Compounds for the treatment of hepatitis c
10/18/2012WO2012141338A1 6,7 - dihydroimidazo [2, 1 - b] [1, 3] oxazine bactericides
10/18/2012WO2012139693A1 Compounds for electronic devices
10/18/2012WO2012139692A1 Materials for electronic devices
10/18/2012WO2012127505A3 Improved process for the preparation of ciprofloxacin and its acid addition salts
10/18/2012US20120264794 Method for Preparing Largazole Analogs and Uses Thereof
10/18/2012US20120264774 Forms of rifaximin and uses thereof
10/18/2012US20120264763 Indoline Anti-Cancer Agents
10/18/2012US20120264749 Morpholine-spirocyclic piperidine amides as modulators of ion channels
10/17/2012EP2511279A1 Divalent and oxabridged heterocyclic neonicotinoid compounds and preparation methods thereof
10/17/2012EP2511269A1 Fused heterocyclic compound having amino group
10/17/2012EP2511268A1 Oxazine derivative
10/17/2012EP2509966A1 Amino oxazine derivatives
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741260A New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
10/17/2012CN102741259A Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
10/17/2012CN102731527A Synthesis method of sirolimus 42-ether derivative
10/17/2012CN102731526A New ansamitocin compounds and preparation method thereof
10/16/2012US8288400 Compositions useful as inhibitors of protein kinases
10/16/2012US8288397 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
10/16/2012US8288375 Fungicidal bicyclic pyrazoles
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 220